Novo Nordisk sues Hims & Hers over patent infringement
Tweet
Share
E-mail
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. REUTERS/Tom Little
COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk said on Monday it has filed a lawsuit against U.S. telehealth company Hims & Hers for infringing on the Danish group's patents.
"Novo Nordisk is asking the court to permanently ban Hims from selling unapproved, compounded drugs that infringe our patents, and is seeking to recover damages," the Danish drugmaker said in a statement.
The move comes after Hims on Saturday cancelled the launch of a $49 copy of a weight-loss pill following legal threats from Novo Nordisk and the U.S. Food and Drug Administration.
(Reporting by Stine Jacobsen, editing by Terje Solsvik)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana surges: Barclays bets big on Medicare star ratings rebound
- Star Fashion Culture stock falls on $9.6M share offering
- Bill Gates demands federal AI guardrails, warns of "a billion deaths"
Create E-mail Alert Related Categories
General News, ReutersRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
